HomeBDTX • NASDAQ
Black Diamond Therapeutics Inc
Follow
$2.33
0.00%
After Hours:(1.25%)-0.029
$2.30
Closed: Jun 20, 6:28:08 PM GMT-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 70.00M | — |
Operating expense | 15.47M | -23.59% |
Net income | 56.54M | 410.24% |
Net profit margin | 80.77 | — |
Earnings per share | 0.98 | 380.00% |
EBITDA | 54.62M | 370.92% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 152.40M | 32.29% |
Total assets | 176.25M | 23.66% |
Total liabilities | 34.73M | -9.12% |
Total equity | 141.52M | — |
Shares outstanding | 56.86M | — |
Price to book | 0.93 | — |
Return on assets | 91.22% | — |
Return on capital | 101.52% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 56.54M | 410.24% |
Cash from operations | 53.41M | 351.95% |
Cash from investing | 8.55M | 162.23% |
Cash from financing | 32.00K | -99.23% |
Net change in cash | 61.99M | 301.24% |
Free cash flow | 31.16M | 312.13% |
Previous close
$2.33
Day range
$2.26 - $2.40
Year range
$1.20 - $6.75
Market cap
132.49M USD
Avg Volume
1.24M
P/E ratio
37.70
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Website
Employees
24
